RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @MRMehraMD: No harm of RAAS inhibitors in COVID - Potential benefit with ACE Inhibitors and Statins? Do these hypothesis generating find…
RT @CharlieTomson: Three papers confirming what @RenalAssoc @escardio and others said all along: RAS inhibitors do not make people more lik…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @dranulala: BOOM. More data supporting understanding of #COVID19 as an endothelial disorder. @Drroxmehran @girish_nadkarni @MRMehraMD @S…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
Good to know that ACEI &ARBs do NOT increase risk of #COVID19. Many decisions are made out of the fear of unknown. We need good data that will drive rational decisions. #datadrivendecisions
RT @AndyBiotech: Three studies in NEJM found no evidence of harm with continued use of ACEi and ARBs in #COVID19 pts w/ hypertension N=891…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
After the storm.....
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @MRMehraMD: No harm of RAAS inhibitors in COVID - Potential benefit with ACE Inhibitors and Statins? Do these hypothesis generating find…
RT @ABsteward: In this large population based study @NEJM Using database from 169 hospitals in Asia, Europe, and North America"~9000 patien…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
Los IECAS y los ARAII para la HTA no se asocian a mayor riesgo en #covid19 pero ojo con los mayores de 65 años, EAC, insuficiencia cardiaca y arritmias cardiacas. #NEJM https://t.co/9Fd8WO5g9j
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM…BP control probably one of the most important public health interventions. https://t.co/okSvIOL6IR
RT @AndyBiotech: Three studies in NEJM found no evidence of harm with continued use of ACEi and ARBs in #COVID19 pts w/ hypertension N=891…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @AndyBiotech: Three studies in NEJM found no evidence of harm with continued use of ACEi and ARBs in #COVID19 pts w/ hypertension N=891…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
So there is actually a physiologic basis for statins being protective in lung injury.
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @MRMehraMD: Many Questions, Varying Opinions, now some data-driven answers - How do Cardiac Medications modify outcome in COVID-19? Card…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @FormigaFrancesc: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/iN5mVVgq4H
RT @AndyBiotech: Three studies in NEJM found no evidence of harm with continued use of ACEi and ARBs in #COVID19 pts w/ hypertension N=891…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
BOOM. More data supporting understanding of #COVID19 as an endothelial disorder. @Drroxmehran @girish_nadkarni @MRMehraMD @SumeetMitter @mayabarghash @EstefaniaOS @IAmDrIbrahim @yaleHFdoc @g_giustinoMD @ajaysmd @mgtrivieri @zahifayad
RT @MRMehraMD: No harm of RAAS inhibitors in COVID - Potential benefit with ACE Inhibitors and Statins? Do these hypothesis generating find…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @catcardiocamfic: Més evidències encara de que el tractament amb IECA/ARA2 en pacients amb HTA i #COVID19 no té efecte perjudicial i, pe…
RT @ABsteward: In this large population based study @NEJM Using database from 169 hospitals in Asia, Europe, and North America"~9000 patien…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @MRMehraMD: Many Questions, Varying Opinions, now some data-driven answers - How do Cardiac Medications modify outcome in COVID-19? Card…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @ABsteward: In this large population based study @NEJM Using database from 169 hospitals in Asia, Europe, and North America"~9000 patien…
RT @catcardiocamfic: Més evidències encara de que el tractament amb IECA/ARA2 en pacients amb HTA i #COVID19 no té efecte perjudicial i, pe…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @JohnNosta: KEY! Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. An interesting (cautious) look at ACE/ARBs and stati…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @JohnNosta: KEY! Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. An interesting (cautious) look at ACE/ARBs and stati…
RT @ABsteward: In this large population based study @NEJM Using database from 169 hospitals in Asia, Europe, and North America"~9000 patien…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @ethanjweiss: Maybe don't stop the statin? https://t.co/Gnp9WieRc1 https://t.co/iqX9ZGiGSJ
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @PharmERToxGuy: Three new large population studies in @NEJM find ACE-Inhibitors and ARBs do NOT increase risk of #COVID19. Cardiovascula…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
First do no harm.
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @catcardiocamfic: Més evidències encara de que el tractament amb IECA/ARA2 en pacients amb HTA i #COVID19 no té efecte perjudicial i, pe…
RT @Nk385: متابعة قاعدة بيانات في ١٦٩ مستشفى حول العالم اتضح ان العوامل التالية تزيد نسبة الوفاة للمصابين بالكورونا ١. أعمار فوق ٦٥ سنة ٢.…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
Més evidències encara de que el tractament amb IECA/ARA2 en pacients amb HTA i #COVID19 no té efecte perjudicial i, per tant, no cal suspendre o canviar el tractament @CAMFiC @catcardio @residentscamfic
RT @Nk385: متابعة قاعدة بيانات في ١٦٩ مستشفى حول العالم اتضح ان العوامل التالية تزيد نسبة الوفاة للمصابين بالكورونا ١. أعمار فوق ٦٥ سنة ٢.…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/NNHARbvpbJ
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/vDaAFN4VPI
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @AndyBiotech: Three studies in NEJM found no evidence of harm with continued use of ACEi and ARBs in #COVID19 pts w/ hypertension N=891…
RT @Babak_Javid_Lab: Statins and ACE-I associated with decreased mortality for Covid (although CVD itself is risk factor for increased mort…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @GilbertDeray: Les barres à droite de la ligne verticale indiquent les facteurs qui augmente le risque de mortalité intra hospitalière.…
RT @JorgeRubenO: 🔷 La enfermedad cardiovascular subyacente se asocia con un mayor riesgo de muerte en el hospital en pacientes #COVID19 🔶…
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/6M0fQXmCKR
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
متابعة قاعدة بيانات في ١٦٩ مستشفى حول العالم اتضح ان العوامل التالية تزيد نسبة الوفاة للمصابين بالكورونا ١. أعمار فوق ٦٥ سنة ٢. تضيق الشرايين ٣. فشل القلب ٤. الالتهابات الرئوية المزمنة ٥. التدخين لم يوجد ارتباط بين نوع ادوية الضغط وارتفاع نسبة الوفيات htt
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @ABsteward: In this large population based study @NEJM Using database from 169 hospitals in Asia, Europe, and North America"~9000 patien…
Buena noticia: los inhibidores de los receptores ACE y los bloqueadores del receptor de angiotensina II (tratamiento en pacientes de hipertensión) no muestran correlación con positividad a Covid-19 o un peor curso clínico. 3 estudios, miles de pacientes.
RT @AndyBiotech: Three studies in NEJM found no evidence of harm with continued use of ACEi and ARBs in #COVID19 pts w/ hypertension N=891…